BVNKF - U.S. monkeypox cases exceed 10000

• According to the latest data compiled by the Centers for Disease Control and Prevention (CDC), the recent monkeypox outbreak has led to 10,392 cases as of Wednesday.
• The country has added 900 cases on Wednesday alone per the Our World in Data project, a public online data hub based at the University of Oxford.
• The U.S. has averaged about 537 cases over the past seven days compared to nearly 979 globally, where the cumulative case count has reached 33,409, including 12 deaths.
• In the latest outbreak, monkeypox, a rare viral disease endemic in Africa, has caused infections mostly among men who have sex with men.
• The Biden administration declared the current monkeypox outbreak a public health emergency last week in a bid to free up emergency funds and raise awareness.
• Vaccine developers targeting monkeypox: Bavarian Nordic ( OTCPK:BVNKF ) ( OTCPK:BVNRY ), Emergent BioSolutions ( EBS ), Chimerix ( CMRX )
• Monkeypox test makers: Co-Diagnostics ( CODX ), Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ), Applied DNA Sciences ( APDN ), Virax Biolabs Group ( VRAX )
• Developers of therapeutics for monkeypox: GeoVax Labs ( GOVX ), SIGA Technologies ( NASDAQ: SIGA ), and Tonix Pharmaceuticals ( TNXP )
• The World Health Organization declared monkeypox a global health emergency in late July.

For further details see: